A Novel Filtration Technique to Treat Open-angle Glaucoma

Minimally invasive microsclerostomy (MIMS) is a bleb-forming MIGS procedure that is short, simple, and stentless.

By Lilit Voskanyan, MD, PhD

Practical Tips for Using iStent Infinite

The new design of this MIGS device makes it easier to achieve good results if you follow these strategies for proper stent placement.

By Sahar Bedrood, MD, PhD

Premium IOLs for POAG Patients

Expand the Toolbox with Multifocal and EDOF Lenses.

By Zarmeena Vendal, MD

Optimizing Drop Size in Ophthalmic Applications

A review of literature on the benefits of smaller drop sizes and tips for using the Nanodropper to dispense medication.

By Constance O. Okeke, MD, MSCE

Protecting the Ocular Surface

A comprehensive overview of treating DED in patients with glaucoma.

By Courtney Bovee, MD

Leading With the Procedure

How (and why) to put interventional glaucoma into practice

By Brian M. Shafer, MD, Mark J. Gallardo, MD

Considering the Time and Money Involved in Prior Authorizations

Getting patients off medications with MIGS procedures, SLT, or procedural pharmaceuticals can ultimately benefit both them and the practice

By Inder Paul Singh, MD

Early iStent infinite Feedback

IOP control in cataract or standalone procedures

By Christy Benson, MD

Optimizing the Continuum of Care

Early intervention leads to better outcomes

By Manjool Shah, MD

From the Editor: Balancing Quality of Life and Glaucoma

By Nathan M. Radcliffe, MD

Bio-scaffolded Cyclodialysis Shows Promising Results

Two physicians discuss the procedure, which uses allograft tissue to open a drainage cleft into the suprachoroidal space.

By Jim Gallagher, senior managing editor

Medicare’s MIGS LCD Finalized

A highly anticipated Medicare coverage policy for microinvasive glaucoma surgery establishes restrictions on coverage.

By Kevin J. Corcoran, COE, CPC, CPMA, FNAO

Regeneron Leaders Recognized for Innovation at Eyecelerator 2024

Drs. Schleifer and Yancopoulos received the Eyecelerator Innovation Award and discussed the long and winding road to success.

By Jim Gallagher, senior managing editor

An Update on SLT Clinical Trials

The ongoing COAST trial hopes to answer the question of which selective laser trabeculoplasty treatment approach is most effective.

By Jim Gallagher, senior managing editor